List of Devices Companies in Norway - 5

Augere Medical is a commercial stage Norwegian medical device company founded in 2018 and is developing systems based on Artificial Intelligence (AI) to improve polyp detection rates during screening for colorectal cancer. The term "augere" is derived from Latin, meaning "to increase" or "to grow" - hence the green color in our logo. It is the root of several words in English and other languages, including "authority," which signifies the power to promote or bring about growth. Augere’s first product, the PolypAID System, is being developed in cooperation with leading colonoscopists and in close cooperation with the research group at Simula. The PolypAID System analyses the real-time video stream during colonoscopy screening and supports the physicians in making the right decision during the screening process. We pledge to implement transparent AI to physicians and patients. These are our values, mission, vision, and tagline statements: OUR VALUES Quality We are delivering high quality products through focus on details and by meeting customer expectations.   Innovation We are in the forefront of the technology development by embracing continuous improvements and investing in our employees.   Care We care about the patients who will benefit from our technologies and put real heart into our promises to our investors and customers.   Agility We move fast and are willing to adapt to changing market conditions regardless of the size of the company.   Delivering results We have grit to deliver results by defining clear objectives and by meeting deadlines. MISSION Making lives better   VISION Augere will, through partnerships with the world's leading clinical and technical research environments, develop a platform for AI-based systems that improve the detection rate and characterization of cancer and precancerous abnormalities and thereby reduce the burden on patients and the cost of cancer treatment   TAGLINE Confidence in outcomes (TM)

CardioMech is a medical device company that is developing a transfemoral, transseptally delivered mitral valve chordal repair technology to treat patients with severe, symptomatic, degenerative mitral regurgitation (DMR) due to prolapse or other structural abnormalities.

High quality nanoparticle-based solutions for life science, diagnostic and aquaculture purposes: We develop and manufacture products within nucleic acid extraction and sample preparation. We serve customers from hospitals, aquaculture and fish health monitoring as well as academic institutions. Our products simplifies and shorten the sample preparation time with up to 50%!

Navamedic is a reliable supplier of high-quality products, delivered to hospitals and through pharmacies, meeting the specific medical needs of patients and consumers. Our product portfolio consists of prescription and OTC pharmaceuticals as well as other healthcare products registered as medical nutrition, medical devices, food supplements or cosmetics. Navamedic is present in all Nordic countries, the Baltics and Benelux and has sales of specific products even in other European countries like UK and Greece. Our headquarter is in Oslo, Norway and we are listed on the Oslo Stock Exchange (ticker: NAVA). We are about 30 highly qualified employees with strong competence in regulatory affairs, quality assurance, reimbursement, marketing and sales and thus a full-service provider securing market access through our local competence.

Regenics AS is a private Norwegian biotechnology company based in Oslo. Regenics develops novel wound care technologies, based on sustainable marine sources.